Stock info Sanofi-Aventis | Filter Basic-Info
Stock: Sanofi-Aventis (Paris main group), ISIN: FR0000120578
| Last Price | 96.30 | Max Price | 104.12 |
| Min Price | 85.69 | 1 Year return | 7.19 |
| Avg. Target | 105.17 | Expected Return | 9.21 % |
| Sector | Health Care | Subsector | Pharmaceuticals |
| Sell | 1 | Rating |
 
|
| Hold | 1 | Concensus |
  
|
| Buy | 4 | ||
| Annual report 2012 |
Sanofi-Aventis is a French pharmaceutical company active on a worldwide scale. Sanofi-Aventis develops and produces medicines. Sanofi-Aventis is one of the world’s largest pharmaceutical companies. The company employs around 30,000 people. Sanofi-Aventis’ stocks are traded on the Euronext Paris and the company is a component of the CAC40-index (ISIN: FR0000120578/ Mnemo: SAN).
Contact info:Street: 54, rue La Boétie Zip Code: 75008 PariCity: Paris Country: FrancePhone: 33 (0)1 53 77 4Website: www.sanofi-aventis.fr
Sector Review Sanofi-Aventis
| Year | Turnover | Total sector | Market share |
|---|---|---|---|
| 2019 | 37,631 | 615,670 | 6.11 % |
| 2020 | 37,369 | 638,104 | 5.86 % |
| 2021 | 39,175 | 727,997 | 5.38 % |
| 2022 | 45,389 | 787,317 | 5.77 % |
| 2023 | 0 | 0 | 0.00 % |
Advice Sanofi-Aventis
News Sanofi-Aventis
High dividend yield Sanofi-Aventis
Sanofi-Aventis in top French dividend returns
Sanofi-Aventis now in top highest dividend yields in France
Sanofi and GlaxoSmithKline granted Indian approval for COVID-19 vaccine trial
Analysts expect over 2021 rising revenue Sanofi-Aventis, quite high dividend
Annual reports Sanofi-Aventis
| 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|
Profile Sanofi-Aventis
Sanofi-Aventis
(FR0000120578)/ SANThe past year yielded positive returns for Sanofi-Aventis investors
Over the last 12 months, that were loss-making period for the investors in Sanofi-Aventis, the stock lost around 3 percent. Over the period 2011-2016 the stock rose a massive 37,06 percent. Sanofi-Aventis's revenues between 2011 and 2015 were relatively steady and moved between 35,96 billion euros and 34,86 billion euros. During 2011 and 2015 Sanofi-Aventis's net results were very volatile and fluctuated between 4,86 billion euros and 4,53 billion euros.
Sanofi-Aventis's head office is located in Paris . Sanofi-Aventis mainly operates in the pharmaceutical sector. The global pharmaceutical companies gained over the past 10 years on average 75 percent. Measured since 2011 the sector is 147 percent higher and over the past 12 months (December 2015-2016) there is a minus of 75 percent.
The French company paid out dividends in the past 5 years. On average Sanofi-Aventis's dividend yield over the past 5 years was around 14 percent annually. Over the period 2011-2015 Sanofi-Aventis raised it's dividends per share each year. So because of the yearly raised dividends per share Sanofi-Aventis is a kind of dividend aristocrat.
Sanofi-Aventis' balance mostly consists of equity
At the end of 2015 the pharmaceutical company's balance sheet equaled 102,32 billion euros. Of the total balance sheet 44,27 billion euros (43,27 percent) was financed by debt. At the end of 2016 the French company was traded with a price/earnings-ratio of around 17. So investors paid 17 times the company's 2015's EPS. We could say that based on it's price/earnings-ratio and dividend yield the French stock can be seen as a value stock.
At the end of 2015 the pharmaceutical company's market capitalization (the number of shares times the market price) equaled around 101,32 billion euros. At the end of 2015 the French company had around 1,31 billion stocks listed on the exchanges.
All Sanofi-Aventis's financial reports are available here. More information about Sanofi-Aventis can be found it's website. .
Results Sanofi-Aventis
| Results |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
|---|---|---|---|---|---|---|
| Revenue |
34,861
|
34,708
|
36,204
|
35,677
|
37,631
|
37,369
|
| Costs |
30,569
|
30,004
|
27,792
|
31,371
|
34,877
|
25,075
|
| Profit |
4,292
|
4,704
|
8,412
|
4,306
|
2,754
|
12,294
|
| Margin of profit |
12.31
|
13.55
|
23.23
|
12.07
|
7.32
|
32.90
|
| ROI |
7.39
|
8.17
|
14.49
|
7.31
|
4.66
|
19.48
|
Balance Sanofi-Aventis
| Balance |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
|---|---|---|---|---|---|---|
| Equity |
58,049
|
57,552
|
58,070
|
58,876
|
59,056
|
63,106
|
| Debt |
44,272
|
47,127
|
41,743
|
52,532
|
53,574
|
51,307
|
| Total assets |
102,321
|
104,679
|
99,813
|
111,408
|
112,630
|
114,413
|
| Solvency |
56.73
|
54.98
|
58.18
|
52.85
|
52.43
|
55.16
|
| Cash |
9,259
|
10,304
|
10,315
|
7,124
|
9,853
|
14,815
|
| Cashflow |
8,897
|
7,853
|
7,379
|
5,547
|
7,715
|
7,418
|
| Employees |
0
|
0
|
0
|
0
|
0
|
|
| Revenue per employee |
0.0
|
0.0
|
0.0
|
0.0
|
0.0
|
|
| Cashflow / Debt |
0.20
|
0.17
|
0.18
|
0.11
|
0.14
|
0.14
|
Details Sanofi-Aventis
| Details |
2016
|
2017
|
2018
|
2019
|
2020
|
|---|---|---|---|---|---|
| Price |
78.19
|
76.50
|
71.48
|
75.27
|
89.15
|
| Eps |
3.63
|
6.64
|
3.43
|
2.19
|
9.76
|
| Price/earnings-ratio |
21.54
|
11.52
|
20.84
|
34.37
|
9.87
|
| Dividend |
2.96
|
3.03
|
3.07
|
3.15
|
3.20
|
| Dividend % |
3.79 %
|
3.96 %
|
4.29 %
|
4.18 %
|
3.32 %
|
| Payout % |
0.82
|
0.46
|
0.90
|
1.44
|
0.33
|
| Book value |
45.25
|
46.31
|
47.27
|
47.10
|
50.46
|
| Market to book |
0.58
|
0.61
|
0.66
|
0.63
|
0.52
|
| Cashflow per stock |
6.17
|
5.89
|
4.45
|
6.15
|
5.93
|
| Stocks |
1,272
|
1,254
|
1,245
|
1,254
|
1,251
|
| Market Cap |
99.452.85
|
95.919.23
|
89.024.77
|
94.375.78
|
120.441.45
|
Dividend Sanofi-Aventis
Price info Sanofi-Aventis
|
Date
|
Price
|
|---|---|
|
09 Jan 2025
|
96.30
|
|
17 Dec 2024
|
88.82
|
|
10 Dec 2024
|
91.82
|
|
06 Dec 2024
|
91.80
|
|
03 Dec 2024
|
91.82
|
|
29 Nov 2024
|
92.10
|
|
27 Nov 2024
|
91.72
|
|
13 Nov 2024
|
94.73
|
|
08 Nov 2024
|
95.73
|
|
05 Nov 2024
|
97.70
|
|
31 Oct 2024
|
98.71
|
|
29 Oct 2024
|
100.78
|
|
23 Oct 2024
|
98.34
|
|
19 Oct 2024
|
100.82
|
|
16 Oct 2024
|
100.38
|
|
14 Oct 2024
|
101.58
|
|
05 Oct 2024
|
101.72
|
|
02 Oct 2024
|
103.92
|
|
27 Sep 2024
|
102.32
|
|
20 Sep 2024
|
104.12
|
|
17 Sep 2024
|
103.32
|
|
13 Sep 2024
|
102.80
|
|
28 Aug 2024
|
100.72
|
|
26 Aug 2024
|
100.82
|
|
23 Aug 2024
|
99.01
|
|
11 Aug 2024
|
96.25
|
|
07 Aug 2024
|
95.25
|
|
05 Aug 2024
|
94.25
|
|
01 Aug 2024
|
95.33
|
|
30 Jul 2024
|
95.78
|
| About us | Network | Partners |
| Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos |
Analist.nlLinksISIN
|
MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-x
|
